Anxiety and sleep disorders in general practice
O. A. Polyakova,
E. Yu. Ebzeeva,
A. V. Dubinina,
S. S. Telkova,
A. V. Asoskova,
L. D. Kozgunova,
O. D. Ostroumova https://doi.org/10.33667/10.33667/2078-5631-2023-13-28-35
Abstract
Anxiety and sleep disorders are an urgent problem of modern healthcare, which should be treated at the earliest possible stages, since this would prevent the development of a wide range of complications of these conditions. At the same time, given the bidirectional relationship between anxiety and sleep disorders, the search and development of safe and effective remedies for their correction is becoming increasingly relevant. The prescription of a set of measures of nonmedicamental and medicamental nature is considered to be the main methods of therapy for anxiety and sleep disorders. This article presents diagnostic tools that allow the general practitioner to identify anxiety and sleep disorders (insomnia) in a patient as early as possible, and discusses the therapeutic strategies for using a combination of glycine and melatonin in appropriate patients.
About the Authors
O. A. Polyakova
Federal State Budgetary Educational Institution of Further Professional Education
«Russian Medical Academy of Continuous Professional Education» of the Ministry
of Healthcare of the Russian Federation
Russian Federation
Russian Federation
Polyakova Olga A., MD, PhD, Assistant Lecturer of the Department of Therapy and
Polymorbid Pathology named after academician M.S. Vovsi
Moscow
E. Yu. Ebzeeva
Federal State Budgetary Educational Institution of Further Professional Education
«Russian Medical Academy of Continuous Professional Education» of the Ministry
of Healthcare of the Russian Federation
Russian Federation
Russian Federation
Ebzeeva Elizaveta Yu., MD, PhD, Associate Professor, Associate Professor and Head of education of the Department of Therapy and Polymorbid Pathology named after academician M. S. Vovsi
Moscow
A. V. Dubinina
Federal State Budgetary Educational Institution of Further Professional Education
«Russian Medical Academy of Continuous Professional Education» of the Ministry
of Healthcare of the Russian Federation
Russian Federation
Russian Federation
Dubinina Anna V., 2nd year resident of the Department of Therapy and Polymorbid Pathology named after academician M.S. Vovsi
Moscow
S. S. Telkova
Federal State Budgetary Educational Institution of Further Professional Education
«Russian Medical Academy of Continuous Professional Education» of the Ministry
of Healthcare of the Russian Federation
Russian Federation
Russian Federation
Telkova Svetlana S., 2nd year resident of the Department of Therapy and
Polymorbid Pathology named after academician M.S. Vovsi
Moscow
A. V. Asoskova
Federal State Budgetary Educational Institution of Further Professional Education
«Russian Medical Academy of Continuous Professional Education» of the Ministry
of Healthcare of the Russian Federation
Russian Federation
Russian Federation
Asoskova Anastasiia V., Assistant Lecturer of the Department of Dermatovenerology and Cosmetology
Moscow
L. D. Kozgunova
Federal State Budgetary Educational Institution of Higher Education “A.I. Yevdokimov Moscow State University of Medicine and Dentistry” of the Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
Kozgunova Lyubov D., 6th year student of the Faculty of Medicine
O. D. Ostroumova
Federal State Budgetary Educational Institution of Further Professional Education
«Russian Medical Academy of Continuous Professional Education» of the Ministry
of Healthcare of the Russian Federation
Russian Federation
Russian Federation
Ostroumova Olga D., MD, PhD, Professor, Head of the Department of Therapy and Polymorbid Pathology named after academician M.S. Vovsi
Moscow
References
1. Selye H. The story of the adaptation syndrome. Canada: Medical Publishers, 1952. 225 p.
2. Kotova O.V., Akarachkova E.S., Belyaev A.A. Psychovegetative syndrome: diagnosis and diagnosis of treatment. Meditsinskiy Sovet. 2018;18(21):50–55. (In Russ.). https://doi. org/10.21518/2079–701X 2018–21–50–55
3. Ebzeeva E. Yu., Polyakova O. A. Anxiety and sleep disorders. Meditsinskiy Sovet. 2022;16(11):108–113. (In Russ.). https://doi.org/10.21518/2079–701X 2022–16–11–108–113
4. Somers JM, Goldner EM, Waraich P. et al. Prevalence and incidence studies of anxiety disorders: a systematic review of the literature. Can. J. Psychiatry. 2006;51(2):100–113. https://doi.org/10.1177/070674370605100206
5. Martín-Merino E, Ruigómez A, Wallander MA. et al. Prevalence, incidence, morbidity and treatment patterns in a cohort of patients diagnosed with anxiety in UK primary care. Fam. Pract. 2010;27(1):9–16. https://doi.org/10.1093/fampra/cmp071
6. Остроумова Т.М., Парфенов В.А., Остроумова О.Д. и др. Артериальная гипертензия и инсомния // Терапевтический архив. 2020;92(1):69–75. https://doi.org/10.26442/00403660.2 020.01.000319
7. Morphy H, Dunn KM, Lewis M. et al. Epidemiology of insomnia: a longitudinal study in a UK population. Sleep. 2007;30(3):274–280. https://doi.org/10.1093/sleep/30.3.274
8. Wilson S, Anderson K, Baldwin D. et al. British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders: An update. J. Psychopharmacol. 2019;33(8):923–947. https://doi.org/10.1177/0269881119855343
9. Staines AC, Broomfield N, Pass L. et al. Do non-pharmacological sleep interventions affect anxiety symptoms? A meta-analysis. J. Sleep. Res. 2022;31(1): e13451. https://doi. org/10.1111/jsr.13451
10. Cox R. C., Olatunji B. O. A systematic review of sleep disturbance in anxiety and related disorders. J. Anxiety. Disord. 2016;37:104–129. https://doi.org/10.1016/j.janxdis.2015.12.001
11. Stein M.B., Enns M.W., Kryger M.H. Sleep in nondepressed patients with panic disorder: II. Polysomnographic assessment of sleep architecture and sleep continuity. J. Affect. Disord. 1993;28(1):1–6. https://doi.org/10.1016/0165–0327(93)90071-q
12. Alfano C.A., Patriquin M.A., De Los Reyes A. Subjective – objective sleep comparisons and discrepancies among clinically-anxious and healthy children. J. Abnorm. Child. Psychol. 2015;43(7):1343–1353. https://doi.org/10.1007/s10802–015–0018–7
13. Soehner AM, Harvey AG. Prevalence and functional consequences of severe insomnia symptoms in mood and anxiety disorders: results from a nationally representative sample. Sleep. 2012;35(10):1367–1375. https://doi.org/10.5665/sleep.2116
14. Foley JE, Weinraub M. Sleep, Affect, and Social Competence from Preschool to Preadolescence: Distinct Pathways to Emotional and Social Adjustment for Boys and for Girls. Front Psychol. 2017;8:711. https://doi.org/10.3389/fpsyg.2017.00711
15. Lovato N, Gradisar M. A meta-analysis and model of the relationship between sleep and depression in adolescents: recommendations for future research and clinical practice. Sleep. Med. Rev. 2014;18(6):521–529. https://doi.org/10.1016/j.smrv.2014.03.006
16. McMakin DL, Alfano CA. Sleep and anxiety in late childhood and early adolescence. Curr. Opin. Psychiatry. 2015;28(6):483–489. https://doi.org/10.1097/YCO.0000000000000204
17. LeBlanc M, Mérette C, Savard J. et al. Incidence and risk factors of insomnia in a population-based sample. Sleep. 2009;32(8):1027–1037. https://doi.org/10.1093/sleep/32.8.1027
18. Taylor D.J., Mallory L.J., Lichstein K.L. et al. Comorbidity of chronic insomnia with medical problems. Sleep. 2007;30(2):213–218. https://doi.org/10.1093/sleep/30.2.213
19. Neckelmann D, Mykletun A, Dahl AA. Chronic insomnia as a risk factor for developing anxiety and depression. Sleep. 2007;30(7):873–880. https://doi.org/10.1093/ sleep/30.7.873
20. Drapkina O. M., Kontsevaya A. V., Kalinina A. M. et al. 2022 Prevention of chronic non-communicable diseases in the Russian Federation. National guidelines. Cardiovascular Therapy and Prevention. 2022;21(4):5–232. (In Russ.). https://doi.org/10.15829/1728– 8800–2022–3235
21. Esin R.G., Esin O.R., Khakimova A.R. Stress-induced disorders. Zhurnal Nevrologii i Psikhiatrii imeni S. S. Korsakova. 2020;120(5):131–137. (In Russ.). https://doi.org/10.17116/ jnevro2020120051131
22. Anxiety-phobic disorders. Clinical recommendations approved by the Ministry of Health of Russia (2021). (In Russ.). Режим доступа: https://cr.minzdrav.gov.ru/recomend/455_2
23. Somnology and Sleep Medicine: National Manual in Memory of A.M. Vein and J.I. Levin. Edited by M.G. Poluektov. Moscow: Med-forum, 2016. 660 p. (In Russ.).
24. Kovalson V.M. Fundamentals of somnology: physiology and neurochemistry of the «waking–sleep» cycle. Moscow: BINOM. Laboratory of Knowledge, 2012. 239 p. (In Russ.)
25. Ostroumova O.D., Kochetkov A.I., Ebzeeva E.Yu. et al. Insomnia and polymorbidity: a training manual. Moscow: Russian Ministry of Health, 2021. 76 p. (In Russ.).
26. Sateia MJ. International classification of sleep disorders-third edition: highlights and modifications. Chest. 2014;146(5):1387–1394. https://doi.org/10.1378/chest.14–0970
27. Shishkova V.N., Nartsissov Ya.R., Titova V.Yu. et al. Molecular mechanisms defining application of glycine and zinc combinationin correction of stress and anxiety main manifestations. Pharmacy & Pharmacology. 2022;10(5):404–415. (In Russ.). https://doi. org/10.19163/2307–9266–2022–10–5–404–415
28. Karna B, Sankari A, Tatikonda G. Sleep Disorder. In: StatPearls. Treasure Island (FL): StatPearls Publishing; January 26, 2023.
29. Godos J, Currenti W, Angelino D. et al. Diet and Mental Health: Review of the Recent Updates on Molecular Mechanisms. Antioxidants (Basel). 2020;9(4):346. https://doi. org/10.3390/antiox9040346
30. File SE, Fluck E, Fernandes C. Beneficial effects of glycine (bioglycin) on memory and attention in young and middle-aged adults. J. Clin. Psychopharmacol. 1999;19(6):506–512. https://doi.org/10.1097/00004714–199912000–00004
31. Inagawa K, Hiraoka T, Kohda T. et al. Subjective effects of glycine ingestion before bedtime on sleep quality. Sleep and Biological Rhythms. 2006;4(1):75–77. https://doi. org/10.1111/j.1479–8425.2006.00193.x
32. Yamadera W, Inagawa K, Chiba S. et al. Glycine ingestion improves subjective sleep quality in human volunteers, correlating with polysomnographic changes. Sleep and Biological Rhythms. 2007;5(2):126–131. https://doi.org/10.1111/j.1479–8425.2007.00262.x
33. Inagawa K, Kawai N, Ono K. et al. Assessment of acute adverse events of glycine ingestion at a high dose in human volunteers. J. Urban. Living. Health Assoc. 2006;50:27–32.
34. Razak MA, Begum PS, Viswanath B. et al. Multifarious Beneficial Effect of Nonessential Amino Acid, Glycine: A Review. Oxid. Med. Cell. Longev. 2017;2017:1716701. https://doi. org/10.1155/2017/1716701
35. Pérez-Torres I, Zuniga-Munoz AM, Guarner-Lans V. Beneficial Effects of the Amino Acid Glycine. Mini Rev. Med. Chem. 2017;17(1):15–32. https://doi.org/10.2174/1389557516666160609081602
36. Bartlett DJ, Biggs SN, Armstrong SM. Circadian rhythm disorders among adolescents: assessment and treatment options. Med. J. Aust. 2013;199(8): S16–S20. https://doi. org/10.5694/mja13.10912
37. Takaesu Y, Futenma K, Kobayashi M. et al. A preliminary study on the relationships between diurnal melatonin secretion profile and sleep variables in patients emergently admitted to the coronary care unit. Chronobiol. Int. 2015;32(6):875–879. https://doi.org /10.3109/07420528.2015.1048869
38. Xie Z, Chen F, Li WA. et al. A review of sleep disorders and melatonin. Neurol. Res. 2017;39(6):559–565. https://doi.org/10.1080/01616412.2017.1315864
39. Geoffroy PA, Etain B, Franchi JA. et al. Melatonin and Melatonin Agonists as Adjunctive Treatments in Bipolar Disorders. Curr. Pharm. Des. 2015;21(23):3352–3358. https://doi.or g/10.2174/1381612821666150619093448
40. Galley HF, Lowes DA, Allen L. et al. Melatonin as a potential therapy for sepsis: a phase I dose escalation study and an ex vivo whole blood model under conditions of sepsis. J. Pineal. Res. 2014;56(4):427–438. https://doi.org/10.1111/jpi.12134
41. Chang YS, Lin MH, Lee JH. et al. Melatonin Supplementation for Children With Atopic Dermatitis and Sleep Disturbance: A Randomized Clinical Trial. JAMA Pediatr. 2016;170(1):35–42. https://doi.org/10.1001/jamapediatrics.2015.3092
42. Lähteenmäki R, Puustinen J, Vahlberg T. et al. Melatonin for sedative withdrawal in older patients with primary insomnia: a randomized double-blind placebo-controlled trial. Br.J. Clin. Pharmacol. 2014;77(6):975–985. https://doi.org/10.1111/bcp.12294
43. Amstrup AK, Sikjaer T, Mosekilde L. et al. The effect of melatonin treatment on postural stability, muscle strength, and quality of life and sleep in postmenopausal women: a randomized controlled trial. Nutr. J. 2015;14:102. https://doi.org/10.1186/s12937–015–0093–1
44. Scheer FA, Morris CJ, Garcia JI. et al. Repeated melatonin supplementation improves sleep in hypertensive patients treated with beta-blockers: a randomized controlled trial. Sleep. 2012;35(10):1395–1402. https://doi.org/10.5665/sleep.2122
45. Gumenyuk V, Belcher R, Drake CL. et al. Differential sleep, sleepiness, and neurophysiology in the insomnia phenotypes of shift work disorder. Sleep. 2015;38(1):119–126. https://doi.org/10.5665/sleep.4336
46. Kaminski RS, Martinez D, Fagundes M. et al. Melatonin prevents hyperglycemia in a model of sleep apnea. Arch. Endocrinol. Metab. 2015;59(1):66–70. https://doi. org/10.1590/2359–3997000000012
47. Xie S, Deng Y, Pan YY– et al. Melatonin protects against chronic intermittent hypoxia-induced cardiac hypertrophy by modulating autophagy through the 5’ adenosine monophosphate-activated protein kinase pathway. Biochem. Biophys. Res. Commun. 2015;464(4):975–981. https://doi.org/10.1016/j.bbrc.2015.06.149
48. Yeung HM, Hung MW, Lau CF. et al. Cardioprotective effects of melatonin against myocardial injuries induced by chronic intermittent hypoxia in rats. J. Pineal Res. 2015;58(1):12–25. https://doi.org/10.1111/jpi.12190
49. Abadir PM, Periasamy A, Carey RM. et al. Angiotensin II type 2 receptor-bradykinin B2 receptor functional heterodimerization. Hypertension. 2006;48(2):316–322. https://doi. org/10.1161/01.HYP.0000228997.88162.a8
50. Sabatini RA, Guimarães PB, Fernandes L. et al. ACE activity is modulated by kinin B2 receptor. Hypertension. 2008;51(3):689–695. https://doi.org/10.1161/HYPERTENSIONAHA.107.091181
Review
For citations:
Polyakova O.A., Ebzeeva E.Yu., Dubinina A.V., Telkova S.S., Asoskova A.V., Kozgunova L.D., Ostroumova O.D. Anxiety and sleep disorders in general practice. Medical alphabet. 2023;(13):28-35. (In Russ.) https://doi.org/10.33667/10.33667/2078-5631-2023-13-28-35
Views:
268
Email this article 